فريق إنت عربي
- Gestala announces $21.6 million funding to develop ultrasound-based brain reading and stimulation without surgery
- The new technology enables direct communication between the brain and digital devices
China-based Gestala, a healthcare startup specializing in ultrasound-based brain-computer interface (BCI) technology, has raised $21.6 million in an early funding round just two months after its founding.
The funding aims to accelerate the development of non-invasive technologies for reading and stimulating brain activity using ultrasound, without the need for surgical intervention.
The investment will support the growth of the brain-computer interface sector in China, reflecting the increasing global interest in technologies that could reshape the future of medicine and human–machine interaction.
Advanced BCI systems enable direct communication between the human brain and digital devices by reading or stimulating neural signals.
Gestala develops solutions based on Focused Ultrasound technology, allowing access to deep regions of the brain without surgery. The company uses advanced techniques capable of penetrating the skull to reach deep neural circuits, monitor brain activity with high precision, and stimulate or suppress specific brain regions without implanting devices in the head.
According to Phoenix Peng, founder of Gestala:
“This approach removes one of the biggest barriers to the widespread adoption of BCI technologies — the risks associated with neurosurgery.”
Peng added that the company is currently developing solutions to treat several neurological and psychiatric disorders, including chronic pain, depression, post-traumatic stress disorder (PTSD), autism, post-stroke rehabilitation, Alzheimer’s disease, and Parkinson’s disease.
